|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |
ABSTRACT |
|---|
|
|
|---|
Airway obstruction in patients with sleep apnea-hypopnea syndrome (SAHS) is due to increased critical pressure (Pcrit) of the upper airway. The ideal nasal pressure (Pn) to maintain airway patency
should consist of the constant term to account for Pcrit and a term (Rn ·
) proportional to flow (
) to
account for the dynamic pressure drop through nasal resistance (R n). Continuous positive airway
pressure (CPAP) applied to avoid flow limitation results in a Pn greater than required over most of the
breathing cycle. The aim was to assess a flow-dependent positive airway pressure (FDPAP) based on
adapting Pn to the instantaneous flow: Pn = P0 + k ·
. FDPAP was tested on collapsible airway models and its applicability was assessed in nine patients with SAHS during sleep. In models, FDPAP prevented flow limitation with lower mean P n and work of breathing than CPAP. In patients FDPAP allowed the patients to breathe normally with a mean Pn (6.6 ± 1.2 cm H2O) systematically and
significantly (p < 0.05, paired t test) lower than when applying CPAP (9.1 ± 1.2 cm H2O). The results
found in models and in patients suggest that adapting the applied nasal pressure to the instantaneous breathing flow may be of potential practical interest in SAHS.
| |
INTRODUCTION |
|---|
|
|
|---|
Patients suffering from the sleep apnea-hypopnea syndrome (SAHS) experience recurrent elevation of airway obstruction associated with partial or total collapse of the upper airway (1- 3). These obstructive events are a consequence of increased airway collapsibility (4). Indeed, in patients with SAHS the critical opening pressure (Pcrit), which is the minimal intraluminal pressure required to maintain upper airway patency, may be increased to values higher than atmospheric pressure during sleep. Consequently, prevention of airway obstruction in these patients requires application of a nasal pressure (Pn) high enough to result in an intraluminal pressure greater that Pcrit at all times. To this end, Pn should be at least equal to Pcrit plus the pressure drop across the resistance of the segment of upper airway from the nostrils to the collapsible airway segment. As this dynamic pressure drop depends on the breathing flow, the pressure at the nasal mask that is just necessary to keep the airflow open varies along the breathing cycle.
The most widespread palliative treatment applied in SAHS, continuous positive airway pressure (CPAP [5, 6]) is not adapted to the fact that the Pn exactly required to maintain airway patency depends at any time on the breathing flow. To prevent airway obstruction, CPAP should be high enough to compensate for the maximal inspiratory dynamic pressure possible (at inspiratory peak flow) and, consequently, the applied Pn is much higher than necessary during most of the breathing cycle. Excessive Pn may unnecessarily worsen the patient's compliance and increase the consequences of high intrathoracic pressure (increased work of breathing due to hyperinflation and possible long-term hemodynamic effects). Bilevel positive airway pressure (7), which consists of applying a lower constant pressure during expiration than inspiration, is also employed to maintain airway patency in patients with SAHS (8). Although this mode of nasal pressure support takes into account the phase of breathing, bilevel pressure may be considered as a variant of CPAP since the applied Pn is not adapted to the continuously changing breathing airflow and is, therefore, not the pressure which is just required to maintain airway patency at any time. Moreover, the sudden changes in Pn between inspiration and expiration, which are characteristic of bilevel pressure, are transmitted to the collapsible airway with the risk of possible instability in the upper airway (9).
The aim of this work was to design and assess a procedure for applying a nasal pressure specifically adapted to maintain airway patency in SAHS. Accordingly, the applied Pn consisted of a constant term to account for the critical pressure of the collapsible upper airway and a time varying term, which was proportional to the instantaneous flow, to account for the dynamic pressure drop due to breathing. This flow-dependent positive airway pressure (FDPAP) was tested on a model study with realistic analogs of the collapsible upper airway, and its practical applicability was assessed on nine patients with SAHS during sleep.
| |
METHODS |
|---|
|
|
|---|
Rationale
According to the Starling model of collapsible airway (Figure 1),
which is commonly used (4) to interpret upper airway collapsibility in
SAHS, a nasal static pressure Pn
Pcrit would be enough to maintain
the airway patency in the absence of flow. However, this is not the
case when breathing because a positive pressure gradient is required
to inspire through the resistance (Rn) of the upper airway segment extended from the nostrils to the collapsible section. Assuming linearity,
the difference from nasal pressure to the intraluminal pressure (P) in
the collapsible airway (Figure 1) for a given flow (
;
> 0 during inspiration) is
|
(1) |
|
and, hence, intraluminal pressure P is
|
(2) |
As airway patency requires an intraluminal pressure always equal to
or greater than the critical opening pressure (P
Pcrit), it follows from
Equation 2 that
|
(3) |
and consequently, Pn should be at least equal to Pcrit plus the dynamic pressure drop across the resistance of the upper airway segment Rn:
|
(4) |
As illustrated in Figure 2 (left) no external Pn is required to maintain
airway patency in healthy subjects. The figure simulates a breathing
flow with normal frequency and amplitude (15 breaths/min, ± 0.5 L/s),
and the corresponding pressure drop (Pn
P; Equation 1) across a
typical nasal resistance Rn = 8 cm H2O · s/L (10). In the normal situation with Pn = 0, intraluminal pressure (P; Equation 2) reaches a minimum value of
4 cm H2O which is much higher than the typical critical pressure (about
13 cm H2O [1, 11]) in healthy subjects. By
contrast, artificial support by means of a positive Pn is required to prevent airway collapse and to allow normal breathing during sleep in patients with SAHS who exhibit a critical pressure higher than normals
(12, 13). For instance, in the simulation of Figure 2 (left) a patient with Pcrit = 6 cm H2O would be unable to breathe owing to airway collapse (obstructive apnea) since at any time P < Pcrit.
|
When CPAP is applied, a nasal pressure:
|
(5) |
where
Imax is maximal inspiratory flow, ensures that at any time intraluminal pressure P
Pcrit (Equation 4). In the simulation example
of Figure 2 (center), CPAP = 10 cm H2O would increase intraluminal
P to a value always greater than the Pcrit = 6 cm H2O. Nevertheless, applying such a CPAP (Equation 5) is not an optimal pressure support
mode since it does not provide the Pn that is exactly required for airway patency, but a value of Pn that is higher than necessary during
most of the breathing cycle. Indeed, intraluminal pressure, which according to Equations 2 and 5, is in this case
|
(6) |
is greater than Pcrit always except at peak inspiratory flow (Figure 2, center).
The designed flow-dependent support mode (FDPAP) was aimed
to continuously adapt Pn to the specific value required to avoid airway
obstruction at any time of the breathing cycle. According to Equation 4, the ideal pressure support to maintain airway patency should consist of a static component to account for the upper airway critical pressure plus a flow-dependent dynamic component to account for the pressure drop from the nostrils and the collapsible segment (Pn
Pcrit + Rn ·
). Consequently, the FDPAP ventilator was designed to apply a nasal
pressure consisting of a constant term and a flow proportional term
|
(7) |
where P0 and k are the parameters of the FDPAP ventilator that can
be modified. Ideally, the optimal pressure would be applied for ventilator settings P0 = Pcrit and k = Rn since in this case the nasal pressure
applied (Equation 7) would coincide with the one required (Equation 4) to allow P = Pcrit, and therefore airway patency would be ensured at
any time with minimal nasal pressure. However, the actual values of
Pcrit and Rn for a given patient are not known a priori and, consequently, application of the FDPAP mode of support requires an estimate of the values of these parameters. To this end, we designed the
following procedure for setting P0 and k. Initially, k was set to k = 0 (i.e., Pn = P0 = CPAP) to determine the optimal CPAP (CPAPopt),
defined as the minimal Pn to avoid flow limitation, specifically at inspiratory peak flow. This would correspond to CPAP = 10 cm H2O in
the simulation of Figure 2 (center) because this is the minimum value
of nasal pressure to ensure P
Pcrit at any time of the breathing cycle.
Once CPAPopt was determined, we followed the algorithm indicated
in Figure 3. From the starting point k = 0 and P0 = CPAPopt, P0 was
decreased by steps of 0.5 cm H2O and k was increased at each step so
as to obtain Pn = CPAPopt at peak inspiration:
|
(8) |
|
This process of modifying P0 and k was progressively repeated. The values of P0 and k that were finally selected were the last settings for which no flow limitation of sleep events were observed, suggesting that P0 was close to Pcrit and k was close to Rn. Accordingly, the Pn applied is the one exactly required for keeping intraluminal pressure P at its minimal possible level (P = Pcrit), as illustrated in the simulation of Figure 2 (right). This figure also shows that the mean nasal pressure with FDPAP (6 cm H2O) is much lower than the one required to maintain airway patency with CPAP (CPAPopt = 10 cm H2O, Figure 2, center).
Setup
The ventilation system developed to generate FDPAP is schematically shown in Figure 4. It was based on a modified bilevel positive
airway pressure (BiPAP) ventilator (Respironics, Inc., Murrysville,
PA) with its conventional tubing and whisper swivel. A Fleisch-II
pneumotachograph (Metabo, Epalinges, Switzerland) plus pressure
transducer (MP-45, ± 2 cm H2O; Validyne, Northridge, CA) and another pressure transducer (MP-45, ± 50 cm H2O; Validyne) allowed
the recording of
and Pn, respectively. Signals
and Pn were analogically low-pass filtered (Butterworth 8-poles, 32 Hz) and sampled at
256 Hz by a computer (486-type PC, 2831 Data Translation board,
Marlboro, MA). The frequency responses of the pressure measuring
systems were flat (± 2%) up to 20 Hz. The BiPAP device was modified to drive its valve coil (14) by means of an external feedback controller. The controller, which was fed with
and Pn as input signals,
consisted of the computer, including its A/D-D/A board and specific
software, and a power amplifier. The system allowed us to continuously modify the settings of P0 and k according to the described procedure (Figure 3) and to drive the valve coil with the voltage required to
generate a nasal pressure Pn = P0 + k ·
(Equation 7). A minimum
Pn = 3 cm H2O was allowed to avoid rebreathing.
|
Model Study
The model study was carried out on an analog of the respiratory system shown in Figure 1. A resistor (Rn) accounted for the resistance
from the nose to the collapsible upper airway. Rn was followed by a
collapsible segment with an external pressure (Pcrit) representing the
critical opening pressure of the collapsible upper airway (1, 4, 12). Pcrit
was imposed by a constant pressure source consisting of an independent CPAP device connected to a partially open shunt valve in parallel. The pump to generate the breathing flow (
) was a computer-controlled mechanical syringe (PWG; MH Custom Design & Mfg L.C.,
Midvale, UT). In the model Pn corresponded to nasal pressure, and
pressure at the outlet of the collapsible segment (Ptr) corresponded to
the pressure at the airway downstream of the collapsible upper airway, i.e., the trachea.
Six models (M1-M6) of the collapsible airway analog (Figure 1)
with various values of Rn, Pcrit, and collapsible tubes were built to test
FDPAP under different mechanical conditions. In model M1 a mesh-wire screen linear resistance Rn = 10.5 cm H2O · s/L was connected to
a collapsible segment made of 21 cm of latex Penrose tube of 19 mm
interior diameter (ID) (Sherwood Medical, Tullamore, Ireland) attached to rigid cylindrical tubes (21 mm ID), subjected to a strain of
5% and enclosed in a small chamber (50 mm ID, 25 cm in length)
where Pcrit was set to 5 cm H2O. The elastance of the tube (Ew) was
virtually nil. The relative weights of the static (Pcrit) and dynamic (Rn ·
) pressure components were modified by building models M2-M4
with the linear resistors (Rn = K1 + K2 ·
; with K2 = 0) specified in
Table 1. To investigate the role of a nonlinear upstream resistance, an
orifice-type nonlinear element was included in model M5 (Table 1). In
order to implement a model with a low compliance collapsible segment, in model M6 (Table 1) the collapsible resistor of models M1-M5
was replaced by a flat and thick rubber tube described in detail in (15) which was characterized by a high elastance and an almost nil section
in the absence of transmural pressure.
|
For each of the models (M1-M6), we applied the described procedure (Figure 3) to determine the ventilator settings (P0 and k) for a sinusoidal breathing with a frequency of 15 breaths/min and a minute volume (Vmin) of 11.25 L/min. The effect of an air leak at the mask level was assessed in model M1 by placing a nonlinear leak resistance [K1 = 7.3 cm H2O · s/L, K2 = 117.5 cm H2O · (s/L)2] between the pneumotachograph and Rn while maintaining the settings previously fixed in the absence of leak. To analyze the response of the CPAP and FDPAP modes to an increased level of breathing, the ventilator settings determined previously were maintained and pump ventilation was increased by 33% from nominal Vmin = 11.25 to 15 L/min. In addition to CPAP and FDPAP, model M1 was also subjected to two settings of bilevel pressure: inspiratory pressure equal to CPAPopt and expiratory pressure of 8 and 4 cm H2O below inspiratory pressure.
Assessment of the performance of the different ventilation modes
was carried out by: (1) computing the mean Pn over an entire breathing cycle (Pn,mean); (2) analyzing the flow curve pattern (
) to detect
the presence of flow limitation; and (3) computing the inspiratory
pressure swings (
Ptr) and the work of breathing (W =
Ptr · dV)
done by the simulated patient (pump) on the upper airway and the
ventilator. Ptr was measured and recorded with equipment identical to
that described for Pn. W was computed as the integral W =
Ptr ·
· dt over an entire breathing cycle (
· dt = dV) divided by the tidal
volume to obtain the work per liter of ventilation.
Patient Study
Nine male patients with severe SAHS, previously documented by full polysomnography, were included in the study (Table 2). The patients, not previously treated for SAHS, had no other active medical problems and had no obstructive pattern in routine pulmonary function tests.
|
In patients the FDPAP ventilator (Figure 4) was connected to a
conventional nasal mask and
and Pn (sampled at the mask) were
recorded as described for the models. Before beginning the study,
with the patient awake in the recumbent position and with all the
equipment connected, we carefully fitted the nasal mask to minimize
leaks. To this end, we applied a CPAP of 5 cm H2O, required the patient to stop breathing for a brief period and, if necessary, adjustments
of the mask were made until leak with CPAP = 5 cm H2O was less
than 50 ml/s. In two of the patients (Patients 8 and 9) esophageal pressure (Pes) was estimated by means of an esophageal balloon connected
to a pressure transducer similar to the one used to measure Pn. The
balloon was positioned and validated as described in the literature
(16). Pes was sampled and recorded in the same way as
and Pn. Application of FDPAP was carried out during a nap period. After the patient achieved a well-established sleep phase according to full polysomnography, at least 1 h of sleep was recorded. Most of the study
was carried out in non-REM sleep. Electroencephalogram (EEG)
(C4/A1, C3/A2), chin electromyogram (EMG), and electro-oculogram (EOG) for sleep staging according to standard criteria (17) were
recorded. SaO2 was measured continuously with a finger probe (504;
Critical Care Systems, Inc., Waukesha, WI). Rib cage and abdominal
motion were monitored by bands placed over the thorax and abdomen. The parameters were recorded continuously on a polygraph
(SleepLab 1000P; Aequitron, Plymouth, MN). Respiratory events were
scored according to commonly used criteria, with apnea defined as
cessation of airflow lasting for 10 s or more and hypopnea as a clear
reduction in airflow lasting 10 s or more, in association with an arousal
or with a cyclical dip in SaO2 (> 4%). Arousals were scored according
to the American Sleep Disorders Association recommendations (18).
The patient was initially subjected to a CPAP = 4 cm H2O by setting P0 = 4 cm H2O and k = 0. Once a well-established sleep stage II
was achieved, P0 (k = 0) was progressively increased to determine the
optimal CPAP (CPAPopt), which in patients was defined as the one required to avoid arousals, apneas, hypopneas, and flow limitation as
detected by the flow curve (19, 20). The settings of P0 and k were determined as previously described (Figure 3). The process of modifying
P0 and k was repeated until further reduction of P0 resulted in flow
limitation provided that sleep remained stable according to the polysomnographic criteria (absence of arousals, apneas, hypopneas, and
flow limitation). The final settings of P0 and k were maintained for the
rest of the nap. In the two patients with esophageal balloon, the work of breathing (Wbr) was computed as the integral Wbr =
Pes ·
· dt
over entire breathing cycles divided by the tidal volume. Results were
expressed as mean ± SD and statistical comparisons of Pn,mean were
made with paired t test. Differences were considered significant when
p < 0.05.
| |
RESULTS |
|---|
|
|
|---|
Model Study
Figure 5 shows Pn,
, and Ptr recorded when model M1 was
subjected to the optimal CPAP (12 cm H2O), to bilevel pressure (12-4 cm H2O), and to FDPAP (P0 = 5.5 cm H2O, k = 11.0 cm H2O · s/L). With CPAPopt, the pressure swing
Ptr required for breathing was 13.2 cm H2O and W = 1.03 J/L. With
bilevel pressure we observed that
and Ptr showed sudden
transients at end-inspiration and end-expiration as a result of
the bilevel Pn applied. With this mode Pn,mean,
Ptr, and W
were considerably reduced to 7.9 cm H2O, 5.8 cm H2O, and
0.302 J/L, respectively. With FDPAP, both Pn,mean and W
showed a further decrease to 6.6 cm H2O and 0.270 J/L, respectively. Moreover, with FDPAP
and Ptr did not show the
sudden transients observed with bilevel pressure. Placing a
leak between the pneumotachograph and Rn on FDPAP mode
resulted in an increase in Pn,mean from 6.6 to 9.0 cm H2O and in
a decrease in W to virtually zero.
|
For the analog configurations including a linear Rn and an
almost ideal Starling resistor (M1-M4), the values of P0 and k determined according to the setting procedure were close
(within 0.5 cm H2O in P0 and 0.5 cm H2O · s/L in k) to the actual Pcrit and Rn (Rn = K1 + K2 ·
), respectively (Table 1). In
model M5, which included a nonlinear Rn, the resulting settings were P0 = 6.5 cm H2O and k = 16.4 cm H2O · s/L. In
model M6 including a stiff collapsible segment the final settings were P0 = 8.0 cm H2O and k = 15.0 cm H2O · s/L. The results shown in Table 1 and Figure 6A, which is a scatter plot of
work versus mean nasal pressure for the different models
(M1-M6), illustrate the performances of CPAP and FDPAP.
When compared with optimal CPAP, FDPAP allowed the
same level of ventilation by applying a lower mean nasal pressure and by requiring lower inspiratory pressure swings and
work of breathing in all the models.
|
The main advantage of FDPAP when compared with
CPAP or bilevel pressure was more apparent as ventilation
was increased. Figure 7 shows the signals recorded when model
M1 was subjected to a 33% increase in ventilation while maintaining the ventilator settings. With bilevel pressure we observed clear flow limitation during the greater part of the inspiration. Such an inspiratory flow limitation was also observed
in CPAPopt since inspiratory Pn was the same.
Ptr increased
considerably to 26.1 cm H2O and, consequently, W rose to
1.76 J/L. By contrast, FDPAP was able to automatically adapt
the nasal pressure so as to account for the increase in dynamic
pressure corresponding to a greater flow. The associated increase in inspiratory nasal pressure with FDPAP (Figure 7)
determined that Pn,mean was similar for FDPAP and bilevel
pressure (7.6 and 8.0 cm H2O, respectively). Nevertheless, the
model could be ventilated sinusoidally with almost the same
breathing effort as in the situation of lower ventilation:
Ptr
was 7.7 cm H2O and W = 0.404 J/L.
|
The response of FDPAP when applied to the other airway models tested under conditions of increased breathing flow was similar to that found in model M1 (Figure 7). As shown in Figure 6B, when ventilation was increased by 33% the response of FDPAP was always better than that of CPAPopt for all the investigated models.
Patient Study
Table 2 shows that, as expected in patients with severe SAHS,
CPAPopt was high (9.1 ± 1.2 cm H2O). During the procedure
for setting P0 and k (Figure 3), P0 could be decreased (normal
breathing pattern and polysomnography) down to a value for
which the patient exhibited an inspiratory flow limitation profile, hypopneas or apneas. We observed that decreasing P0 by
another step of 0.5 cm H2O usually resulted in apneas and
clear polysomnographic events. As described in METHODS the
final settings of FDPAP (Table 2) were the last values of P0
and k before the appearance of flow limitation or sleep events
(Figure 3). According to the polysomnography criteria, all the
patients showed normalized sleep when subjected to FDPAP.
Figure 8 shows an example of the flow and nasal pressure recorded in one of the patients during application of FDPAP.
The figure also shows signals Pn and
recorded when a CPAP
with a Pn,mean similar to that of FDPAP was applied to the same
patient. With FDPAP, the patient was able to breathe with a
normal flow pattern. By contrast, when subjected to the CPAP
mode with a similar Pn,mean the flow signal displayed the typical pattern of inspiratory flow limitation.
|
As shown in Figure 9, mean nasal pressure systematically
and considerably decreased (p < 0.01) by application of FDPAP when compared with CPAPopt. On average Pn,mean was
reduced from 9.1 ± 1.2 cm H2O for CPAP to 6.6 ± 1.2 cm H2O
for FDPAP. In the two patients with esophageal balloon we
found that, in addition to reducing Pn,mean, application of FDPAP decreased the esophageal pressure swing (
Pes) and the
work of breathing Wbr. In Patient 8,
Pes were 8.4 and 6.6 cm
H2O and Wbr were 0.54 and 0.45 J/L for CPAPopt and FDPAP,
respectively. In Patient 9,
Pes were 8.3 and 6.5 cm H2O and
Wbr were 0.63 and 0.55 J/L for CPAPopt and FDPAP, respectively.
|
| |
DISCUSSION |
|---|
|
|
|---|
To maintain airway patency the intraluminal pressure in the collapsible airway must be at least equal to the critical opening pressure of the airway. However, the nasal pressure that should be applied to avoid airway obstruction in patients with SAHS does not coincide with the value of the critical airway pressure (Equation 4). This is due to the dynamic pressure drop associated with airflow through the resistance from the nostrils to the collapsible airway (Equation 1). Consequently, the rationale of FDPAP is based on adapting the nasal pressure to the instantaneous flow so that the amplitude of the applied pressure is minimized and its time pattern is matched with the actual patient's flow.
An advantage of FDPAP, when compared with CPAP and bilevel pressure, is that the FDPAP mode of support is aimed at automatically compensating for any change in the patient's ventilation. Indeed, as illustrated in the model study the optimal CPAP and the inspiratory bilevel pressure are titrated to eliminate flow limitation at peak inspiration for a certain level of flow. Consequently, the CPAP and the bilevel models of support decreased Ptr just to Pcrit (Figure 5). Therefore, increasing ventilation, as in Figure 7, while maintaining the ventilator settings resulted in flow limitation. In this condition of increased ventilation, maintaining airway patency with CPAP or bilevel pressure would require a higher Pn to prevent flow limitation. This, however, would further increase nasal and intrathoracic pressures. By contrast, FDPAP was able to autoregulate Pn (Equation 7) when ventilation was increased (Figure 7). If, instead of increasing, flow decreased, the CPAP and bilevel modes would apply a Pn greater than necessary any time, even at peak inspiration. Nevertheless, in this instance of decreased ventilation FDPAP would reduce Pn to the level strictly necessary at all times during the breathing cycle.
The FDPAP is based on applying a nasal pressure with a constant component and a component proportional to flow (Equation 7). From the technical viewpoint of pressure generation, FDPAP is similar to proportional assist ventilation (PAV) (21) with settings for only flow support and with added positive end-expiratory pressure (PEEP). The only difference would be that FDPAP is applied both during inspiration and expiration and PAV is intended to apply flow-proportional pressure only during inspiration. Nevertheless, despite the technical similarity between FDPAP and PAV, it is worth noting that the rationale for using these two approaches is completely different. Indeed, with PAV Pn is aimed at providing a pressure in proportion to the patient's muscle effort in order to compensate for a respiratory system with increased impedance and/ or weakened inspiratory muscles. The addition of PEEP is addressed to compensate for dynamic hyperinflation (22). By contrast, FDPAP is aimed at maintaining airway patency by applying the nasal pressure required to avoid static and dynamic airway obstruction at any time during the breathing cycle (Equation 4). Consequently, the constant term P0 corresponds to the critical pressure of the supper airway and k represents only a fraction of the total respiratory resistance (Rn: upstream the collapsible segment). Accordingly, we defined a process (Figure 3) for setting the ventilation parameters (P0, k) which took into account the particular mechanical problem to solve in the application of pressure support in SAHS.
The suitability of FDPAP for reducing the pressure support (Pn,mean) and the breathing work (W) required to allow
normal breathing was confirmed when applied to a variety of
analog airway models characterized by different Pcrit, Rn, and
airway wall compliance (Figure 6, Table 1) and in patients
(Figures 8 and 9). In fact, greater reductions in Pn,mean and W
could be obtained if the minimal Pn = 3 cm H2O, which we
fixed to avoid rebreathing in our setup, were not necessary,
for instance by using a ventilator with separate inspiratory and
expiratory lines. When applied in patients FDPAP allowed us
to reduce the magnitude of nasal support for a Pn,mean of 9.1 ± 1.2 cm H2O to 6.6 ± 1.2 cm H2O (Figure 9). The estimated value of the critical pressure (P0) was on average 5.9 cm H2O (Table 2), which is in keeping with the values measured conventionally in patients with severe SAHS (12, 13). Moreover,
the value of the upper airway resistance estimated by applying
FDPAP (k = 5.2 ± 1.8 cm H2O · s/L was consistent with the
values of lung (23, 24) and respiratory (25) resistance measured by other methods in the absence of flow limitation,
which was the case in our patients during application of FDPAP. In the model study, FDPAP was particularly performant
with models M1-M4 simulating an almost pure Starling resistor. Moreover, the designed mode of support was also useful
when applied to more complex and realistic airway analogs
(M5, M6) exhibiting nonlinear Rn (10, 26) or with a collapsible
segment which does not behave as a pure Starling resistor (8).
In these instances, the setting procedure resulted in values of
P0 (6.5 and 8.0 cm H2O for M5 and M6, respectively) which
were slightly greater than the effective Pcrit (5.0 and
6 cm
H2O for M5 and M6 [15], respectively). The values of estimated Rn (k) were also greater than expected: for M5 the
value of k = 16.4 cm H2O · s/L corresponded to the resistance
of the nonlinear Rn at flow 0.5 L/s, and for M6 k was 56%
greater than the actual Rn. In this regard, it should be noted
that FDPAP is conceptually based on the assumption that Pcrit
and Rn remain constant (Starling model in Figure 1). This
means that the collapsible tube presents only two possible
states (open or closed) according to the transluminal pressure.
However, the upper airway in patients with SAHS does not
exactly meet this assumption owing to nonlinearities in the upper airway resistance (10, 26), to hysteresis phenomena in the
critical pressure (19), and to the static elastic properties of the
airway wall (27). In the case of nonlinear Rn or in a collapsible
tube with relatively stiff wall (and hence with a resistance depending on transluminal pressure), the settings of P0 and k are
not expected to exactly coincide with Pcrit and Rn. However, the
procedure (FDPAP) of applying a nasal pressure with a static
(P0) and a dynamic (k ·
) component is expected to be effective in reducing Pn,mean and W, as occurred in models M5 and
M6. This suggests that comparison of the estimates of Pcrit and
Rn obtained from FDPAP and from other methods used in the literature (4, 10, 12, 13) could allow us to test the adequacy of
the models used to interpret airway mechanics in SAHS and,
hence, to better characterize the pathophysiology of the collapsible upper airway.
Practical application of FDPAP in patients may be affected by a possible air leak in the mask. Indeed, with such a leak the flow measured by the pneumotachograph is greater than actual flow and consequently, the applied Pn is higher than required. However, when assessing the importance of this problem we found that even a considerable level of air leak (0.25 L/s) resulted in a modest nasal overpressure (2.4 cm H2O). Moreover, the presence of air leaks high enough to produce a significant misestimation of actual breathing flow can be automatically detected and quantified from the pneumotachograph flow signal. A second concern which may arise from the application of FDPAP in patients is related to the fact that this mode of support assumes that the estimates (P0, k) of Pcrit and Rn obtained during the setting procedure remain constant. This, however, may not be the case because Pcrit and Rn change in the short time (posture and sleep phase [28], alcohol ingestion [29]) or over a longer time period (change in body weight [30] or adaptation to treatment [31, 32]). To solve this practical shortcoming, which is in common with CPAP titration, it is possible to implement the concept of autotitration (33, 34) to FDPAP. To this end, the ventilator could be programmed for periodically repeating the setting procedure to update P0 and k according to the actual changes in Pcrit and Rn.
The application of FDPAP to our patients with SAHS during sleep showed that this support procedure was well tolerated and that it allowed the patients to sleep normally with a mean pressure level significantly lower than in the case of CPAP. These preliminary results suggest that FDPAP has a potential interest both in optimizing the treatment and in better understanding the mechanisms determining upper airway obstruction in SAHS. However, future clinical work should be aimed at ascertaining whether FDPAP is effectively useful in maintaining airway patency while reducing intrathoracic pressure and improving patient compliance.
| |
Footnotes |
|---|
Correspondence and requests for reprints should be addressed to Dr. Ramon Farré, Lab. Biofisica i Bioenginyeria, Facultat de Medicina, Casanova 143, E-08036 Barcelona, Spain.
(Received in original form October 15, 1997 and in revised form January 28, 1998).
Dr. R. Peslin was a Visiting Professor at the University of Barcelona.Acknowledgments: The authors thank Mr. M. A. Rodríguez and the nurses of the Servei de Pneumologia (Hospital Clinic de Barcelona) for their assistance.
Supported in part by Comisión Interministerial de Ciencia y Tecnología (CICYT, SAF96-0076).
| |
References |
|---|
|
|
|---|
1. Deegan, P. C., and W. T. McNicholas. 1995. Pathophysiology of obstructive sleep apnoea. Eur. Respir. J 8: 1161-1178 [Abstract].
2.
Remmers, J. E.,
W. J. DeGroot,
E. K. Sauerland, and
A. M. Anch.
1978.
Pathogenesis of upper airway occlusion during sleep.
J. Appl. Physiol
44:
931-938
3.
White, D. P..
1995.
Pathophysiology of obstructive sleep apnoea.
Thorax
50:
797-804
4.
Gold, A. R., and
A. R. Schwartz.
1996.
The pharyngeal critical pressure:
the whys and hows of using nasal continuous positive airway pressure
diagnostically.
Chest
110:
1077-1088
5. Sullivan, C. E., F. G. Issa, M. Berthon-Jones, and L. Eves. 1981. Reversal of obstructive sleep apnea by continuous positive airway pressure applied through the nares. Lancet 1: 862-865 [Medline].
6. American Thoracic Society. 1994. Indications and standards for use of nasal continuous positive airway pressure (CPAP) in sleep apnea syndromes. Am. J. Respir. Crit. Care Med 150: 1738-1745 [Medline].
7.
Sanders, M. H., and
N. Kern.
1990.
Obstructive sleep apnea treated by
independently adjusted inspiratory and expiratory positive airway
pressure via nasal mask: physiological and clinical implications.
Chest
98:
317-324
8. Reeves-Hoché, M. K., D. W. Hudgel, R. Meck, R. Wittenam, A. Ross, and C. W. Zwillich. 1995. Continuous versus bilevel positive airway pressure for obstructive sleep apnea. Am. J. Respir. Crit. Care Med 151: 443-449 [Abstract].
9. Levy, P., J. L. Pepin, and G. Ferretti. 1994. Dynamique des structures pharyngées au cours des apnées obstructives (en ventilation spontanée, pression positive continué et BiPAP). Neurophysiol. Clin 24: 227-248 [Medline].
10.
Hudgel, D. W.,
P. Devadatta, and
H. Hamilton.
1993.
Pattern of breathing and upper airway mechanics during wakefulness and sleep in
healthy elderly humans.
J. Appl. Physiol
74:
2198-2204
11.
Schwartz, A. R.,
P. L. Smith,
R. A. Wise,
A. R. Gold, and
S. Permutt.
1988.
Induction of upper airway occlusion in sleeping individuals with
subatmospheric nasal pressure.
J. Appl. Physiol
64:
535-542
12. Gleadhill, I. C., A. R. Schwartz, N. Schubert, R. A. Wise, S. Permutt, and P. L. Smith. 1991. Upper airway collapsibility in snorers and in patients with obstructive hypopnea and apnea. Am. Rev. Respir. Dis 143: 1300-1303 [Medline].
13.
Smith, P. L.,
R. A. Wise,
A. R. Gold,
A. R. Schwartz, and
S. Permutt.
1988.
Upper airway pressure-flow relationships in obstructive sleep
apnea.
J. Appl. Physiol
64:
789-795
14. Kacmarek, R. M., and D. Hess. 1994. Equipment required for home mechanical ventilation. In M. J. Tobin, editor. Principles and Practice of Mechanical Ventilation. McGraw-Hill, New York.
15. Farré, R., R. Peslin, M. Rotger, and D. Navajas. 1997. Inspiratory dynamic obstruction detected by forced oscillation during CPAP. Am. J. Respir. Crit. Care Med 155: 952-956 [Abstract].
16. Baydur, A., P. K. Behrakis, W. A. Zin, M. Jaeger, and J. Milic-Emili. 1982. A simple method for assessing the validity of the esophageal balloon technique. Am. Rev. Respir. Dis 126: 788-791 [Medline].
17. U.S. Public Health Service. 1963. A Manual of Standarized Terminology, Techniques and Scoring System for Sleep Stages of Human Subjects. A. Rechtschafen and A. Kales, editors. U.S. Government Printing Office, Washington, DC. 204.
18. ASDA Report. 1992. EEG arousal: scoring rules and examples. Sleep 15: 174-184 .
19. Condos, R., R. G. Norman, I. Krishnasamy, N. Peduzzi, R. M. Goldring, and D. M. Rapoport. 1994. Flow limitation as a noninvasive assessment of residual upper-airway resistance during continuous positive airway pressure therapy of obstructive sleep apnea. Am. J. Respir. Crit. Care Med 150: 475-480 [Abstract].
20. Montserrat, J. M., E. Ballester, H. Olivi, A. Reolid, P. Lloberes, A. Morello, and R. Rodriguez-Roisin. 1995. Time-course of stepwise titration. Am. J. Respir. Crit. Care Med 152: 1854-1859 [Abstract].
21. Younes, M.. 1992. Proportional assist ventilation: a new approach to ventilatory support: theory. Am. Rev. Respir. Dis 145: 114-120 [Medline].
22. Younes, M. 1994. Proportional assist ventilation. In M. J. Tobin, editor. Principles and Practice and Mechanical Ventilation. McGraw-Hill, New York.
23.
Hudgel, D. W.,
R. J. Marin,
B. Johnson, and
P. Hill.
1984.
Mechanics of
the respiratory system and breathing pattern during sleep in normal
humans.
J. Appl. Physiol
56:
133-137
24.
Morell, M. J.,
H. R. Harty,
L. Adams, and
A. Guz.
1995.
Changes in total
pulmonary resistance and PCO2 between wakefulness and sleep in normal human subjects.
J. Appl. Physiol
78:
1339-1349
25. Navajas, D., R. Farré, M. Rotger, and J. M. Montserrat. 1996. Assessment of airway obstruction by means of the forced oscillation technique during application of CPAP in patients with SAS (abstract). Am. J. Respir. Crit. Care Med 153: A772 .
26.
Anch, A. M.,
J. E. Remmers, and
H. Bunce III..
1982.
Supraglottic airway resistance in normal subjects and patients with occlusive sleep apnea.
J. Appl. Physiol
53:
1158-1163
27.
Isono, S.,
J. E. Remmers,
A. Tanaka,
Y. Sho,
J. Sato, and
T. Nishino.
1997.
Anatomy of pharynx in patients with obstructive sleep apnea
and in normal subjects.
J. Appl. Physiol
82:
1319-1326
28.
Issa, F. G., and
C. E. Sullivan.
1984.
Upper airway closing pressures in
obstructive apnea.
J. Appl. Physiol
57:
520-527
29. Robinson, R. W., D. P. White, and C. W. Zwillich. 1985. Moderate alcohol ingestion increases upper airway resistance in normal subjects. Am. Rev. Respir. Dis 132: 1238-1241 [Medline].
30. Schwartz, A. R., A. R. Gold, N. Schubert, A. Stryzak, R. A. Wise, S. Permutt, and P. L. Smith. 1991. Effect of weight loss on upper airway collapsibility in obstructive sleep apnea. Am. Rev. Respir. Dis 144: 494-498 [Medline].
31. Monton, C., J. M. Montserrat, O. Parra, J. Kimoff, and M. Cosío. 1994. Disminución del requerimiento del nivel de CPAP tras un tratamiento prolongado en pacientes con síndrome de apneas obstructivas durante el sueño. Arch. Bronconeumol 30: 385-389 [Medline].
32. Sériès, F., I. Marc, Y. Cormier, J. La, and Forge. 1994. Required levels of nasal continuous positive airway pressure during treatment of obstructive sleep apnoea. Eur. Respir. J. 7: 1776-1781 [Abstract].
33. Meurice, J. C., I. Marc, and F. Series. 1996. Efficacy of auto-CPAP in the treatment of obstructive sleep apnea/hypopnea syndrome. Am. J. Respir. Crit. Care Med 153: 794-798 [Abstract].
34. Berthon-Jones, M., S. Lawrence, C. E. Sullivan, and R. Grunstein. 1996. Nasal continuous positive airway pressure treatment: current realities and future. Sleep 19: S131-S135 [Medline].
This article has been cited by other articles:
![]() |
R. Farre, J. M. Montserrat, J. Rigau, X. Trepat, P. Pinto, and D. Navajas Response of Automatic Continuous Positive Airway Pressure Devices to Different Sleep Breathing Patterns: A Bench Study Am. J. Respir. Crit. Care Med., August 15, 2002; 166(4): 469 - 473. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. FARRE, M. MANCINI, M. ROTGER, M. FERRER, J. ROCA, and D. NAVAJAS Oscillatory Resistance Measured during Noninvasive Proportional Assist Ventilation Am. J. Respir. Crit. Care Med., September 1, 2001; 164(5): 790 - 794. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Lévy and J.-L. Pépin Autoadjusting Continuous Positive Airway Pressure . What Can We Expect? Am. J. Respir. Crit. Care Med., May 1, 2001; 163(6): 1295 - 1296. [Full Text] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Proc. Am. Thorac. Soc. | Am. J. Respir. Cell Mol. Biol. |